GSK-3β and Memory Formation
In Alzheimer’s disease (AD), tau hyperphosphorylation and neurofibrillary tangle (NFT) formation are strongly associated with dementia. Memory impairment is a characteristic, early symptom of AD. Glycogen synthase kinase 3 β (GSK-3β), which is activated in response to amyloid β (Aβ) formation,...
Main Author: | Akihiko eTakashima |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-04-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2012.00047/full |
Similar Items
-
Tau oligomers impair memory and synaptic plasticity through the cellular prion protein
by: Claudia Balducci, et al.
Published: (2025-01-01) -
Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum
by: Kok Pin Ng, et al.
Published: (2022-09-01) -
LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
by: Daniela Puzzo, et al.
Published: (2017-07-01) -
Silencing I2PP2A rescues tau pathologies and memory deficits through rescuing PP2A and inhibiting GSK-3β signaling in human tau transgenic mice
by: Yao eZhang, et al.
Published: (2014-06-01) -
Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
by: Mei Wang, et al.
Published: (2024-12-01)